The TAP Study: Treating People Who Inject Drugs in Community-Based Settings Using a Social Network Approach

Summary

This study will investigate the feasibility of treating people who inject drugs (PWID) with hepatitis C virus (HCV) in community-based settings with a 12-week course of oral therapy combination of sofosbuvir plus ledipasvir. It will also measure the effectiveness of using a social network-based approach to reduce HCV incidence among PWID.

Timeline

Start

2015-02

Primary completion

2018-12

Completion

2019-12

Drugs

Indications